inner-banner-bg

Archives of Epidemiology & Public Health Research(AEPHR)

ISSN: 2833-4353 | DOI: 10.33140/AEPHR

Impact Factor: 1.98

Research Article - (2023) Volume 2, Issue 1

The Double-edged Sword of Antioxidant Supplements on Metabolic Diseases, A Necessity for Quantification of Oxidative Status

Wei Zheng Zhang 1 *
 
1VIDRL and The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne 30, Australia
 
*Corresponding Author: Wei Zheng Zhang, VIDRL and The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne 30, Australia

Received Date: Jan 30, 2023 / Accepted Date: Feb 06, 2023 / Published Date: Feb 08, 2023

Copyright: ©Wei Zheng Zhang This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation: Wei Zheng Zhang (2023). The Double-edged Sword of Antioxidant Supplements on Metabolic Diseases, A Necessity for Quantification of Oxidative Status. Arch Epidemiol Pub Health Res, 2(1), 168-171.

Abstract

Cells produce reactive oxygen species (ROS) as by-products of metabolism, which can give rise to a two-sided effect on the body under balanced and imbalanced oxidant homeostasis conditions. Antioxidant supplements exert their beneficial efficacy in the treatment of metabolic diseases only when the oxidant homeostasis is imbalanced with the over-production of ROS. Over-supplementation of antioxidant(s) can also cause an imbalanced oxidant homeostasis to exert detriments to the induction of metabolic diseases. This commentary raises a concern that prior to precise supplementation of antioxidants, an establishment of oxidant homeostasis status is required in avoiding an imbalanced oxidant homeostasis in vivo. In searching for valid oxidant stress makers, 3-Nitrotyrosine seems to fit in with the selection criteria and its quantification can be correlated with the degree of oxidative stress in vivo.

Keywords

Antioxidant Supplements; ROS; Oxidative Stress Analysis; Metabolic Diseases

Introduction

Consumption of antioxidant supplements has become popular since the1990's, forming a multi-billion-dollar market capacity. They are a group of substances including vitamins, minerals and plant extracts or synthetic chemicals that enable to erase or inhibit or regulate the production of reactive oxygen species (ROS) and derivatives. Following the discovery that overproduced-oxygen free radicals play a pivotal role in the pathogenesis of many met¬abolic diseases [1,2], a widely spread marketing of antioxidants as vital health-giving nutrients has begun and still is continuing. Since they are available without medical prescription and profes¬sional guidance, the detrimental effects have appeared clinically and could become a public health disaster if they are not regulat¬ed or misused by the general population. The current commentary aims to explore the clinical evidence of the benefits and detriments of antioxidant supplements with possible mechanisms and to rec¬ommend the oxidative status to be quantified for corrective con¬sumption.

Benefits of Administration of Antioxidant Supplements

Cell metabolisms produce harmful compounds of free oxidative radicals or ROS, which can be destroyed or neutralized by the ex-isting anti-free-radical compounds of the antioxidant system under physiological conditions. However, over-produced such radicals under some pathophysiological conditions, and our body cannot be able to eliminate them in vivo can cause oxidative stress and trigger a series of reactions with cell membranes, proteins/en-zymes, carbohydrates, and DNA. Those reactions interfere with cell metabolisms and survival, resulting in disturbance of cellular normal division and functions, block of energy generation, dam¬age of DNA, and interruption of biochemical signaling. Despite free oxidative radicals within a normal range or under certain con¬ditions playing a defensive role in protecting from microbiological infections and in maintaining normal cell metabolism and func¬tion, oxidative stress becomes a key factor in the development of metabolic syndrome and other metabolic disorders, cardiovascular diseases, neurodegenerative disorders, cancers, and acceleration of aging [3]. Antioxidants play a pivotal role in fighting against oxi¬dative stress [4]; supplements of nutritional antioxidants attempt to protect against the detrimental effects of ROS, assuming a normal diet only could not achieve a correct balance between oxidants and antioxidants; exogenous antioxidants could accomplish the protec¬tion against those diseases in addition to exogenous antioxidants [5]. Enormous literature and press have frequently publicized the benefits of antioxidant consumption, including its efficacy in many "incurable" disease treatments and in prolonging the life span of a healthy individual.

Antioxidants of vitamins D and C as immune boosters have been applied in enhancing the immune system, protecting from viral infection, and reducing inflammatory reactions to promote an improvement of immunity in fighting COVID-19 [6,7]. Vitamin C supplementation improves endothelial function and creatinine clearance in kidney transplant recipients despite it is prone to kid-ney stones and interacts with its essential medicine of cyclosporine [8]. Supplementation of vitamins E and C combination can de-celerate atherosclerotic progression [26]. A healthy pregnancy and optimal fetal development could be beneficial from an adequate supply of selenium [9] and patients with obstructive sleep apnea [10]. The mixtures of selenium and antioxidant could reduce CVD and all-cause mortality risk [20]. Some antioxidant supplements on the market demonstrate cardioprotective effects attributed to antioxidant and anti-inflammatory properties [11] in the manage¬ment of cardiovascular disease prevention [12]. It may be attain¬able to use antioxidant supplementals in reducing the damage of traumatic brain injury [16]. The plant-antioxidant supplements have been suggested as adjuvant strategies in chemotherapy with platinum drugs [13]. Antioxidant supplementation may improve an antioxidant-oxidant balance in patients with liver disease dis¬played by modestly improved liver function test results [14]. Cu¬rative cancer therapies implement antioxidant supplementation to reduce the treatment side effects in achieving a better tolerance for the treatment and in improving quality of life, despite the antiox¬idants may interfere with the cytotoxic effects of chemotherapy if used improperly [15]. Although the effectiveness of antioxidant supplements could differ by type of antioxidants [16] with no firmed evidence on the improvement of lifespan, beneficial effects of antioxidant supplements seem undoubtful in anticipation of an¬tioxidant deficiencies [17].

Detriments of Administration of Antioxidant Supplements

Over the last decades of administration of antioxidant supplements, many detriments have been clinically discovered in individual us¬ers. Those detrimental effects can offset the purposed benefits, and become a concern of the complications caused by unrestricted ad¬ministration of the supplements in addition to many uncertainties of the effectiveness. Whether antioxidant supplements could be beneficial for patients with liver diseases [18] or justify usefulness in critically ill patients [19] or reduce risks of pancreatic cancer incidence and mortality in a nonlinear dose-response pattern [20] or mitigate adverse health effects associated with traffic-related air pollution [21] are still uncertain. In comparison with an optimal antioxidant-rich diet in a healthy population [22], the intake of individual antioxidants scarcely achieves health benefits even at high doses in patients during cancer treatment despite the possible side effects induced by oversupplied antioxidants [23,24] and the association with risks of pancreatic cancer incidence and mortality in a nonlinear dose-response pattern [20]. Vitamin E supplement has shown an inverse association with CVD in interventional trials [25]. Large-scale trials could not support the continued use of an¬tioxidants to mitigate free-radical-induced changes in the cardio¬vascular system [27]. The randomized trials on vitamin A, vitamin E, or selenium treatments have shown no significant effect or even increased mortality of several diseases [26]. Supplementation of antioxidants to patients with metabolic syndrome is still contradic- tory due to the counterproductive effects of excessive blocking on ROS production [27).

The detrimental effects of antioxidants may exert disturbances of redox homeostasis. Normal and stable redox homeostasis is a pre¬requisite for normal cell metabolism, differentiation, growth, DNA repair, survival, absorption of certain minerals, immunity, and de¬fense against pathogens since cell biochemical signaling and in¬tegrity require normal levels of free radicals to maintain. Clinical studies have revealed that an optimal source of antioxidants can be obtained from our diet but may not be sufficient from the supple¬ments of pills or tablets [28]. Due to the detrimental effects of anti-oxidant supplements and the extensive marketing of such products continued, a compelling proposal has been raised to register them as medicinal products and to undergo sufficient evaluation prior to promotion [29]. Antioxidant supplements may not possess preven¬tive effects and may be harmful with unwanted consequences for our health, especially in well-nourished populations. Therefore, further study should be focused on the limited efficacy or even harmful effects of antioxidant supplementation and the effective dose, supplement formulation, timing of administration, or various populations [21].

Determination of Redox Homeostasis Status is a Key to Accu- rate Dosing

In general, a "correction" of an imbalanced redox homeostasis undertakes those benefits achieved by antioxidant supplements in vivo; but an "oversupply" of antioxidants may cause those detri¬ments. An imbalance of the redox species between ROS and anti¬oxidants could cause cell dysfunction and death, and the efficacy of antioxidant supplementation relies on the capability of correc¬tion to ROS over-production. The ROS status in redox homeosta¬sis becomes a necessity for antioxidant selection or supplemental quantity, given that more antioxidant(s) is not better or even worse. It could be plausible that over-dosing of the supplement(s) could eliminate the potential benefit(s) of antioxidant administration, which actually may induce an unjustified clinical side effect(s) [30]. Analysis of oxidative stress quantitative levels individually, therefore, becomes a necessity prior to the administration of most antioxidant supplements in gaining the proposed benefits without harmfulness. A quantitative baseline level as an index, once es¬tablished, could be beneficial in overcoming the discrepancy in the different efficiencies among individuals caused by absorbance or the efficacy of the possible derivatives, in the establishment of individual dose recommendations, or in monitoring the prognosis of metabolic and other disorders in vivo.

Accurate and direct quantification of ROS is a challenging task, due to ROS having a very short half-life. The practicable approach is to indirectly measure the stable by-product which is modified under oxidative stress induced proportionally by ROS and exists in circulation as a biomarker. The recognized oxidative stress mark¬ers of ROS vary consisting of small molecules, enzymes, and pro¬teins or derivatives. Due to many practical difficulties in obtaining clinical specimen(s), analyte stability, accessibility of instrumen- tation, analytical specificity, sensitivity, and reproducibility [31], reliable markers are scarce. In spite of the challenge of the selec-tion of reliable oxidative stress biomarkers, 3-Nitrotyrosine (3NT) has become an outstanding candidate, fitting in with these criteria. 3NT is one of the promising biomarkers that is formed by oxi-dative stress through nitration of protein-bound and free tyrosine residues by the reactive peroxynitrite molecules involving ROS generation, well-established being a stable molecule in circula-tion. A simplified and commonly accessible analytical method has been developed and validated for the quantitative determination of blood 3NT to assess oxidative stress clinically [32]. Selection of an integrative panel of multi-markers is also recommended for the quantification of oxidative stress in humans [33) and 3NT should be one of them.

Conclusion

Oxidative stress involves in the pathogenesis of many metabol¬ic diseases. Supplementation of antioxidants can confront ROS over-produced under pathophysiological conditions to achieve a profound treatment for the disease. Due to a variety of oxidative homeostasis exists among individuals and over-supplementation of antioxidant(s) could be inefficacy or harmful, accurate dosing individually becomes a great issue for treatment of the metabolic diseases. Marketing for those supplements must be aware of the adverse effects. In avoiding any potential detriments of the sup-plements, the oxidative status of individuals should be determined for accurate dosing. A reliable biomarker for oxidative stress status should be established and to be analyzed individually prior to sup¬plementation. Among the potential biomarkers of oxidative stress, 3-NT seems promising to act as a reliable biomarker with its close correlation to the degree of oxidative stress and is ready for clini¬cal applications.

References

  1. Thomas DT, Delcimmuto NR, Flack KD, Stec DE, Hinds TD. Reactive Oxygen Species (ROS) and Antioxidants as Immu-nomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. Vol. 11, Antioxidants. 2022.
  2. Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, GriendlingKK. Reactive oxygen species in metabolic and inflammatory signaling. Vol. 122, Circulation Research. 2018.
  3. Jîtca G, Osz BE, Tero-Vescan A, Miklos AP, Rusz CM, Batrînu MG, et al. Positive Aspects of Oxidative Stress at Different Levels of the Human Body: A Review. Vol. 11, Antioxidants. 2022.
  4. Ranjit S. Ambad, Sonal Muley, Lata Kanyal Butola, Ajinkya S. Ghogare. Association of Antioxidant to the Genesis of Psy­chiatric Disorder. Int J Res Pharm Sci. 2021;12(1).
  5. Abdel-Daim MM, El-Tawil OS, Bungau SG, Atanasov AG. Applications of Antioxidants in Metabolic Disorders and De­generative Diseases: Mechanistic Approach. Vol. 2019, Oxi­dative Medicine and Cellular Longevity. 2019.
  6. Vaidyanathan GS, Aishwarya B, Ahmad I, Selvam SP, Ku­mar MM, Sadiku ER. Review on boosting up body's natu­ral defence mechanism and suppression of symptoms against SARS-CoV-2 (Covid-19): A review. Vol. 33, Asian Journal of Chemistry. 2021.
  7. Rezaei H, Khiali S, Rezaei H, Rezaee H, Baghi HB, Pourghasem M, et al. Potential roles of vitamins in the man­agement of COVID-19: A comprehensive review. Vol. 27, Pharmaceutical Sciences. 2021.
  8. Borran M, Dashti-Khavidaki S, Alamdari A, Naderi N. Vita­min C and kidney transplantation: Nutritional status, potential efficacy, safety, and interactions. Vol. 41, Clinical Nutrition ESPEN. 2021.
  9. Modzelewska D, Solé-Navais P, Brantsæter AL, Flatley C, Elfvin A, Meltzer HM, et al. Maternal dietary selenium intake during pregnancy and neonatal outcomes in the norwegian mother, father, and child cohort study. Nutrients. 2021;13(4).
  10. Saruhan E, Sertoglu E, Unal Y, Bek S, Kutlu G. The role of antioxidant vitamins and selenium in patients with obstructive sleep apnea. Sleep Breath. 2021;25(2).
  11. Banez MJ, Geluz MI, Chandra A, Hamdan T, Biswas OS, Bryan NS, et al. A systemic review on the antioxidant and an­ti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Vol. 78, Nutrition Research. 2020.
  12. Ali MA, Nasir M, Pasha TN, Javid I, Muzaffar R, Rashid A, et al. Preventive therapy of antioxidant vitamins against the blood choline levels in cardiovascular patients. Cell Mol Biol. 2020;66(4).
  13. Stankovic JSK, Selakovic D, Mihailovic V, Rosic G. Antiox­idant supplementation in the treatment of neurotoxicity in­duced by platinum-based chemotherapeutics—a review. Vol. 21, International Journal of Molecular Sciences. 2020.
  14. Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberg-er M, Leonard SW, et al. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J Nutr. 2014;144(2).
  15. Wieland LS, Moffet I, Shade S, Emadi A, Knott C, Gorman EF, et al. Risks and benefits of antioxidant dietary supplement use during cancer treatment: Protocol for a scoping review. BMJ Open. 2021;11(4).
  16. Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Welt-zien E, et al. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life after Cancer Epidemiology (LACE) cohort. Cancer. 2012;118(8).
  17. Sadowska-Bartosz I, Bartosz G. Effect of antioxidants supple­mentation on aging and longevity. Biomed Res Int. 2014;2014.
  18. Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C. Meta-analysis: Antioxidant supplements for liver diseases - The Cochrane Hepato-Biliary Group. Aliment Phar­macol Ther. 2010;32(3).
  19. Gudivada KK, Kumar A, Shariff M, Sampath S, Varma MM, Sivakoti S, et al. Antioxidant micronutrient supplementation in critically ill adults: A systematic review with meta-analysis and trial sequential analysis. Clin Nutr. 2021;40(3).
  20. Zhong GC, Pu JY, Wu YL, Yi ZJ, Wan L, Wang K, et al.Total antioxidant capacity and pancreatic cancer incidence and mortality in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2020;29(5).
  21. Barthelemy J, Sanchez K, Miller MR, Khreis H. New oppor­tunities to mitigate the burden of disease caused by traffic related air pollution: Antioxidant-rich diets and supplements. Vol. 17, International Journal of Environmental Research and Public Health. 2020.
  22. Astori E, Garavaglia ML, Colombo G, Landoni L, Portinaro NM, Milzani A, et al. Antioxidants in smokers. Vol. 35, Nutri­tion Research Reviews. 2022.
  23. Adewumi Akanji M, Demilade Fatinukun H, Emmanuel Rotimi D, Lawrence Afolabi B, Stephen Adeyemi O. The Two Sides of Dietary Antioxidants in Cancer Therapy. In: Antioxi­dants - Benefits, Sources, Mechanisms of Action. 2021.
  24. Sur D, Gorzo A, Sabarimurugan S, Krishnan SM, Lungulescu CV, Volovat SR, et al. A Comprehensive Review of the Use of Antioxidants and Natural Products in Cancer Patients Re­ceiving Anticancer Therapy. Anticancer Agents Med Chem. 2021;22(8).
  25. Violi F, Nocella C, Loffredo L, Carnevale R, Pignatelli P. In­terventional study with vitamin E in cardiovascular disease and meta-analysis. Free Radic Biol Med. 2022;178.
  26. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, GluudC. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. Vol. 297, JAMA. 2007.
  27. Casuso RA, Huertas JR. Antioxidant supplements in obesity and metabolic syndrome: Angels or demons. In: Obesity: Ox­idative Stress and Dietary Antioxidants. 2018.
  28. Bjelakovic G, Nikolova D, Gluud C. Antioxidant supplements and mortality. Vol. 17, Current Opinion in Clinical Nutrition and Metabolic Care. 2014.
  29. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, GluudC. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Sao Paulo Med J. 2015;133(2).
  30. Gudivada KK, Kumar A, Sriram K, Baby J, Shariff M, Sam­path S, et al. Antioxidant micronutrient supplements for adult critically ill patients: A bayesian multiple treatment compari­sons meta-analysis. Clin Nutr ESPEN. 2022;47.
  31. Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: Applications to cardio­vascular research and practice. Vol. 1, Redox Biology. 2013.
  32. Zhang WZ, Lang C, Kaye DM. Determination of plasma free 3-nitrotyrosine and tyrosine by reversed-phase liquid chroma­tography with 4-flouro-7-nitrobenzofurazan derivatization. Biomed Chromatogr. 2007;21(3).
  33. Squillacioti G, Guglieri F, Colombi N, Ghelli F, Berchialla P, Gardois P, et al. Non-invasive measurement of exercise-in-duced oxidative stress in response to physical activity. A systematic review and meta-analysis. Vol. 10, Antioxidants. 2021.